Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/94510/1/j.1527-5299.2003.00294.x.pd
Rationale: Long-term clinical implications of beta-blockade in obstructive airway diseases remains c...
Background: Beta-blockers are often prescribed to patients with heart failure (HF) without distincti...
BACKGROUND: Beta-blockers (BBs) are the mainstay prognostic medication for all stages of chronic hea...
β-blockers represent a mainstay in the pharmacological approach to patients affected by heart failur...
Background: To assess the influence of β2-receptor suppression on top of selective β1-receptor block...
© 2017, Springer-Verlag Berlin Heidelberg. Aims: Beta-blockers are recommended for the treatment of ...
Three beta-blockers--carvedilol, metoprolol, and bisoprolol--reduce mortality in chronic heart failu...
For more than 3 decades, beta-blockers have been widely used in the treatment of hypertension and ar...
Patients with diabetes and heart failure have been increasing due to Japanese Cardiac Registry of He...
The success of b-blocking agents in treating mild tomoderate heart failure has generated a debate ov...
Back ground: Little data exist to demonstrate the tolerability of β-blocker therapy in an unsel...
Abstractβ-Adrenergic receptor blockers or β-blockers represent one of the oldest classes of cardiova...
BACKGROUND: Randomized trials have demonstrated the efficacy of selected beta-blockers in systolic h...
The role of beta-adrenergic receptor antagonists in cardiovascular therapy has been the subject of v...
Background: β-Blockers are often associated with further cardiac function deterioration, ledding to ...
Rationale: Long-term clinical implications of beta-blockade in obstructive airway diseases remains c...
Background: Beta-blockers are often prescribed to patients with heart failure (HF) without distincti...
BACKGROUND: Beta-blockers (BBs) are the mainstay prognostic medication for all stages of chronic hea...
β-blockers represent a mainstay in the pharmacological approach to patients affected by heart failur...
Background: To assess the influence of β2-receptor suppression on top of selective β1-receptor block...
© 2017, Springer-Verlag Berlin Heidelberg. Aims: Beta-blockers are recommended for the treatment of ...
Three beta-blockers--carvedilol, metoprolol, and bisoprolol--reduce mortality in chronic heart failu...
For more than 3 decades, beta-blockers have been widely used in the treatment of hypertension and ar...
Patients with diabetes and heart failure have been increasing due to Japanese Cardiac Registry of He...
The success of b-blocking agents in treating mild tomoderate heart failure has generated a debate ov...
Back ground: Little data exist to demonstrate the tolerability of β-blocker therapy in an unsel...
Abstractβ-Adrenergic receptor blockers or β-blockers represent one of the oldest classes of cardiova...
BACKGROUND: Randomized trials have demonstrated the efficacy of selected beta-blockers in systolic h...
The role of beta-adrenergic receptor antagonists in cardiovascular therapy has been the subject of v...
Background: β-Blockers are often associated with further cardiac function deterioration, ledding to ...
Rationale: Long-term clinical implications of beta-blockade in obstructive airway diseases remains c...
Background: Beta-blockers are often prescribed to patients with heart failure (HF) without distincti...
BACKGROUND: Beta-blockers (BBs) are the mainstay prognostic medication for all stages of chronic hea...
DOI
Add to ORKG